Dong-A ST anchors ESG in ‘warm’ growth strategy

Dong-A ST is internalizing its environmental, social and governance (ESG) management strategy to push for a leading role in the global pharmaceutical industry.

In its recently released '2025 Sustainable Management Report,' the company disclosed its year-long ESG strategy, implementation efforts and key achievements last year. The report was developed in alignment with GRI Standards, SASB and TCFD guidelines, while incorporating the 10 core principles of the United Nations Global Compact.

Dong-A ST’s ESG pivot centers on its “Warm On” framework, symbolizing a warm-hearted approach to emerge as a global biopharmaceutical leader by its centennial anniversary in 2032.

With last year’s initiative, anchored by the core pillars of ethical management, innovative drug research and development, rigorous quality control and a positive workplace culture, the company broadened the reporting framework to encompass the sustainability strategies of its subsidiaries by including Dong-A Chammed, Abtis and Ecowin.

These efforts have gained recognition in external evaluations. Dong-A ST has maintained an “A” grade for five consecutive years from the Korea Institute of Corporate Governance and Sustainability. It also received a “Gold” rating from EcoVadis, a sustainability assessment platform.

With the government’s “net zero” emissions push, the company laid out a mid- to long-term road map on renewable energy expansion, including environmentally friendly equipment investments procurement.

Dong-A ST also scaled up its social responsibility initiatives, creating employment opportunities for people with disabilities and a youth program, while also broadening its global social responsibility by providing medical and pharmaceutical aid to developing nations such as Ethiopia and Cambodia.

With ESG at its core, the company aims to secure growth in main business streams such as new drug development, digital health care and biosimilars.

“Guided by our core philosophy of respecting life, we remain committed to elevating our ESG practices to emerge as a frontrunner in the global healthcare market," a Dong-A ST representative said.

BY LEE SOYOUN [[email protected]]